title: Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas.
abstract: Samples were taken from supratentorial gliomas border and normal brain autopsy which were divided into four groups, these including eight cases normal brain tissues, 30 cases of astrocytomas, 25 cases of anaplastic astrocytomas and 22 cases of glioblastomas. Cathepin B (CB) expression and microvessel density (MVD) were determined with immunohistochemical studies. Staining results of CB was scored according to the percentage of positive cells, graded as negative (-), weak (+), moderate (++), and strong (+ + +). MVD was analyzed by Weidner's revised technique. CB positive staining was negative in eight cases of normal brain tissue. Only 9 out of 30 cases of astrocytomas showed a low percentage of positive cells that were stained in a light, diffuse cytoplasmic pattern (score +). Twenty-two out of 35 cases of anaplastic astrocytomas showed positive light, granular staining pattern, it including five samples (score +), and 17 samples (score + +). In contrast, all 22 cases of glioblastomas were stained all, and it was present in a course, granular staining pattern with an intensity of score (+ +) of two sample, and score (+ + +) of 20 samples. Positive staining tumor cells were found in extracellular matrix (ECM), basement membrane (BM), and the endothelial cells of blood vessels were also positive stained. Along with elevating glioma grade, CB expression and MVD value were both increased. Therefore, it showed MVD value was positive correlated with expression of CB. It highly suggested that CB and angiogenesis plays an important role in glioma progression.
authors.affiliation: Department of Neurosurgery, The First Hospital, Xi'an Jiaotong University, 710061, No. 1 Jiankang Road, Xi'an, China. maodewang@yahoo.com.cn
authors.forename: Maode
authors.initials: M
authors.lastname: Wang
authors.forename: Jianjian
authors.initials: J
authors.lastname: Tang
authors.forename: Shouxun
authors.initials: S
authors.lastname: Liu
authors.forename: Daizo
authors.initials: D
authors.lastname: Yoshida
authors.forename: Akira
authors.initials: A
authors.lastname: Teramoto
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001254:Astrocytoma / Q000098:blood supply* / Q000201:enzymology* / Q000473:pathology; D002401:Cathepsin B / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000473:pathology; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D005909:Glioblastoma / Q000098:blood supply / Q000201:enzymology / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000473:pathology; D012720:Severity of Illness Index; D015173:Supratentorial Neoplasms / Q000098:blood supply* / Q000201:enzymology* / Q000473:pathology
chemical_list: D002401:Cathepsin B
references.citation: Biol Chem Hoppe Seyler. 1992 Jul;373(7):611-22
references.pmid: 1515091
references.citation: Biochem J. 1992 Feb 15;282 ( Pt 1):273-8
references.pmid: 1540143
references.citation: Anat Rec. 1998 Oct;252(2):281-9
references.pmid: 9776083
references.citation: Oncogene. 2002 Dec 12;21(57):8705-12
references.pmid: 12483523
references.citation: J Neurooncol. 2002 May;58(1):21-32
references.pmid: 12160137
references.citation: Hum Pathol. 1999 Jun;30(6):680-6
references.pmid: 10374777
references.citation: Br J Cancer. 1999 Oct;81(3):510-9
references.pmid: 10507778
references.citation: Eur J Biochem. 2000 Jul;267(13):4165-70
references.pmid: 10866820
references.citation: FEBS Lett. 1999 Jul 23;455(3):286-90
references.pmid: 10437790
references.citation: Cancer Gene Ther. 2003 Feb;10(2):141-51
references.pmid: 12536203
references.citation: Am J Pathol. 1990 Nov;137(5):1121-42
references.pmid: 1700617
references.citation: Neurosurgery. 2002 Mar;50(3):578-86; discussion 586-8
references.pmid: 11841727
references.citation: Biochim Biophys Acta. 1993 Jul 28;1178(1):55-62
references.pmid: 8329457
references.citation: J Neuropathol Exp Neurol. 1999 Oct;58(10):1029-40
references.pmid: 10515226
references.citation: Clin Exp Metastasis. 1992 May;10(3):145-55
references.pmid: 1582084
references.citation: Neurosurgery. 2003 Jan;52(1):187-96; discussion 196-7
references.pmid: 12493117
references.citation: J Pathol. 1997 Jun;182(2):205-10
references.pmid: 9274532
references.citation: Cancer Res. 1989 Sep 1;49(17):4870-5
references.pmid: 2758418
references.citation: Cell. 1991 Jan 25;64(2):327-36
references.pmid: 1703045
references.citation: J Biol Chem. 2000 Apr 28;275(17):12806-12
references.pmid: 10777578
references.citation: Surg Today. 2001;31(5):385-9
references.pmid: 11381499
references.citation: Biol Chem. 1998 Feb;379(2):125-30
references.pmid: 9524063
references.citation: Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):483-94
references.pmid: 10571410
references.citation: Am J Pathol. 1998 Aug;153(2):429-37
references.pmid: 9708803
references.citation: Oncogene. 2001 Jun 21;20(28):3665-73
references.pmid: 11439329
references.citation: Cancer. 1996 Jan 15;77(2):362-72
references.pmid: 8625246
references.citation: Int J Oncol. 2001 Sep;19(3):519-24
references.pmid: 11494030
references.citation: Brain Pathol. 1994 Apr;4(2):157-66
references.pmid: 7520326
references.citation: J Neurosurg. 1995 Aug;83(2):285-90
references.pmid: 7542317
references.citation: N Engl J Med. 1991 Jan 3;324(1):1-8
references.pmid: 1701519
references.citation: J Clin Oncol. 1998 Mar;16(3):1013-21
references.pmid: 9508185
references.citation: Anticancer Res. 1997 Nov-Dec;17(6D):4747-53
references.pmid: 9494601